NCT04947124 2025-01-20A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101Qlaris Bio, Inc.Phase 2 Completed3 enrolled
NCT05495269 2025-01-20Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)Qlaris Bio, Inc.Phase 2 Completed2 enrolled